For suppression and re-stimulation assays, T cells were enriched

For suppression and re-stimulation assays, T cells were enriched using Dynal CD4 positive isolation kit, using the manufacturer’s protocol. Efficiency of depletion and preparation purity was routinely less than 95% as assessed by flow cytometry. Stimulator bone marrow DCs were generated by granulocyte macrophage colony-stimulating factor differentiation of bone marrow isolates as previously described [50]. Cell cultures were performed in complete media, composed of RPMI 1640 (Sigma, Poole, UK) medium supplemented with

100 IU/mL penicillin, 100 μg/mL streptomycin, 2 mM L-glutamine, 0.01 M Hepes, 50 μM 2β-mercaptoethanol (Invitrogen, Paisley, UK), and 10% heat-inactivated foetal calf serum (FCS) (SERAQ, Sussex, UK). Cells were selleck kinase inhibitor maintained at 37°C in a humidified

atmosphere with 5% CO2. Treg cells were isolated by positive selection of CD4+CD25+ cells from pooled spleen and lymph nodes from B6 mice as described above. Treg cells with specificity for autologous-MHC antigen, direct specificity for H2-Ab MHC class II or indirect specificity for H-2Kd MHC class I were generated and expanded as previously described [51]. In brief, to expand alloantigen-specific Treg DAPT cells with direct specificity, freshly isolated Treg cells were stimulated weekly with BALB/c DCs. To expand Treg cells with indirect allospecificity, isolated Treg cells were retrovirally transduced with TCR genes and then stimulated weekly with B6 DCs pulsed with Kd peptide54–68. Auto-specific Treg-cell lines were generated by repeated stimulation with autologous many B6 DCs. Treg-cell lines were cultured with 10 U/mL IL-2 (Roche, UK) and all stimulator DCs were γ-irradiated (300 cGys). Treg-cell lines were used for in vivo studies 1 week after their last re-stimulation to ensure Treg cells were in a “resting” state. A total of 5 × 106 single-cell suspensions of experimental GVHD splenocytes, or 1 × 105 Treg cells were labelled with fluorochrome-conjugated antibodies (CD8, H2-Kd MHC class I, B220, CD4

and Thy1.1 from eBioscience, Hatfield UK, and Vβ13 from BD Biosciences Oxford, UK) and analyzed on an FACSCalibur™, using Cell Quest™ software (BD Biosciences). FoxP3 staining was performed using a murine FoxP3 kit following the manufacturer’s instructions (BD Biosciences). Analysis was performed with FlowJo software (Treestar). For suppression experiments, 5 × 104 CD4+ T cells were used as responders, and were stimulated with γ-irradiated (300 cGy) APCs (T-cell depleted splenocytes) prepared from CBA, BALB/c, B6 or CB6F1 mice as indicated (1 × 105 cells/well). For antigen-specific T-cell responses, 0.1–2 μg/mL ovalbumin peptide (OVA323–339) or H-2Kd peptide (Kd54–68) were added to cultures. Assays were performed in 96-well round-bottomed plates. CD4+ T cells alone or stimulated with CD3CD28-coated beads were used as negative and positive controls. After 48 h, cells were pulsed with 1 μCi/well 3H thymidine (Amersham Pharmacia, UK).

Comments are closed.